Verbal memory deficit in patients with schizophrenia: an important future target for treatment
- PMID: 15853614
- DOI: 10.1586/14737175.4.1.43
Verbal memory deficit in patients with schizophrenia: an important future target for treatment
Abstract
Despite more than two-thirds of patients with schizophrenia showing reductions in delusions and hallucinations following optimum available treatment, many are left with crippling cognitive impairments. Neurocognitive deficit is a core feature of schizophrenia, but the question arises as to whether efforts should be geared towards ameliorating and normalizing these deficits. Verbal memory dysfunction is one of the most consistently reported cognitive deficits and among the best predictors of functional outcome in schizophrenia. Therefore, a better understanding of the nature of this deficit could lead to treatments that not only improve the specific systems mediating the impairment, but could also have wider implications for clinical and social outcome.
Similar articles
-
Cognition in schizophrenia: impairments, determinants, and functional importance.Psychiatr Clin North Am. 2005 Sep;28(3):613-33, 626. doi: 10.1016/j.psc.2005.05.004. Psychiatr Clin North Am. 2005. PMID: 16122570 Review.
-
Treatment of cognitive dysfunction in schizophrenia.Clin Ther. 2005;27 Suppl A:S25-37. doi: 10.1016/j.clinthera.2005.07.015. Clin Ther. 2005. PMID: 16198199 Review.
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
[Memory disorders in schizophrenia].Encephale. 1992 Jul-Aug;18 Spec No 2:315-28. Encephale. 1992. PMID: 1363948 Review. French.
-
Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.Curr Med Res Opin. 2007 Mar;23(3):575-83. doi: 10.1185/030079906X167372. Curr Med Res Opin. 2007. PMID: 17355738 Clinical Trial.
Cited by
-
Expression of TCN1 in Blood is Negatively Associated with Verbal Declarative Memory Performance.Sci Rep. 2018 Aug 23;8(1):12654. doi: 10.1038/s41598-018-30898-5. Sci Rep. 2018. PMID: 30139959 Free PMC article.
-
Neuropsychological Impairment in Prodromal, First-Episode, and Chronic Psychosis: Assessing RBANS Performance.PLoS One. 2015 May 14;10(5):e0125784. doi: 10.1371/journal.pone.0125784. eCollection 2015. PLoS One. 2015. PMID: 25973925 Free PMC article.
-
High-intensity interval training and active video gaming improve neurocognition in schizophrenia: a randomized controlled trial.Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):339-353. doi: 10.1007/s00406-020-01200-4. Epub 2020 Nov 6. Eur Arch Psychiatry Clin Neurosci. 2021. PMID: 33156372 Clinical Trial.
-
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study.BMJ Open. 2021 Nov 25;11(11):e054160. doi: 10.1136/bmjopen-2021-054160. BMJ Open. 2021. PMID: 34824121 Free PMC article.
-
Ten year neurocognitive trajectories in first-episode psychosis.Front Hum Neurosci. 2013 Oct 7;7:643. doi: 10.3389/fnhum.2013.00643. eCollection 2013. Front Hum Neurosci. 2013. PMID: 24109449 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical